The planned trial is designed for patients whose multiple myeloma has returned or resisted treatment after at least three prior lines of therapy.
In rats, islets delivered through the liver’s portal vein had taken hold one month later, supporting the delivery route planned for clinical testing.
The company is developing a purpose-built laboratory platform to collect large-scale training data on how cells change over time and under treatment.
Developers will have access to immune profiling and detailed donor assessments, intended to help them evaluate the starting material used to make donor-derived cell therapies.
Cellular Intelligence, backed by the Chan Zuckerberg Initiative, is building an AI model to predict how cells respond to signals over time, supported by a capsule platform that enables exponential experimentation. Here’s...
The experimental product isolates and purifies factors released by lab-grown iPS-derived cells, with foundational studies examining age-related changes in tissues including skin and hair.
FUJIFILM Cellular Dynamics will present a practical framework for standardizing, automating and scaling iPSC-derived therapy manufacturing.
Researchers used whole-genome sequencing and a machine-learning RNA assay to assess dopamine neuron precursors made from patients’ skin cells for identity and consistency.
The initial program will use qualified perinatal starting materials and the licensed Dezawa Method, with product-specific testing and release criteria.
The operational site and its team have completed 145 batches under good manufacturing practice standards, enabling immediate client onboarding.